Fluoroscopy Equipment Market to Reach USD 11.6 Billion by 2033 at 6.6% CAGR; North America Leads with 39.6% Share - Key Players: Siemens Healthineers, GE HealthCare, Philips Healthcare

The global fluoroscopy equipment market was valued at approximately USD 8.6 billion in 2025 and is projected to reach around USD 11.6 billion by 2033, growing at a CAGR of 6.6% during the forecast period from 2026 to 2033. The market is witnessing strong growth driven by increasing prevalence of cardiovascular, orthopedic, gastrointestinal, and neurological disorders requiring real time imaging and minimally invasive interventions. Rising adoption of image guided surgical procedures, expanding use of mobile C arm systems, and growing demand for advanced interventional radiology technologies are significantly contributing to market expansion globally. In addition, advancements in digital fluoroscopy systems, AI assisted imaging software, flat panel detector technologies, and low radiation dose imaging solutions are improving diagnostic accuracy, procedural efficiency, and patient safety across healthcare facilities.

The market is also benefiting from increasing regulatory approvals, rising investments in advanced imaging infrastructure, and continuous product innovations by leading medical device companies. Regulatory authorities such as the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) continue to support innovation in fluoroscopic imaging technologies through streamlined approval pathways and updated radiation safety standards. Companies including Siemens Healthineers, GE HealthCare, Philips Healthcare, and Canon Medical Systems Corporation are actively focusing on AI integrated fluoroscopy platforms, robotic assisted imaging systems, and portable fluoroscopic solutions to strengthen their competitive position in the global market. Furthermore, increasing demand for hybrid operating rooms and growing adoption of minimally invasive surgical procedures are creating substantial growth opportunities for the fluoroscopy equipment market worldwide.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/fluoroscopy-equipment-market?sai-v

Key Developments

February 2026: Rising adoption of AI-enabled fluoroscopy systems and advanced real-time imaging platforms across North America and Europe improved procedural accuracy and workflow efficiency in minimally invasive surgeries. Major companies including Siemens Healthineers, GE HealthCare, and Philips Healthcare accelerated deployment of low-dose fluoroscopy and smart imaging technologies.

January 2026: Increasing investments in hybrid operating rooms and interventional radiology infrastructure across the United States, Germany, China, and Japan strengthened demand for advanced fluoroscopy equipment. Canon Medical Systems and Shimadzu Corporation expanded fluoroscopy imaging portfolios supporting cardiovascular, orthopedic, and gastrointestinal procedures.

December 2025: Growing prevalence of cardiovascular disorders and rising demand for minimally invasive procedures across Asia-Pacific accelerated adoption of digital fluoroscopy systems and mobile C-arm technologies. Medtronic plc and Boston Scientific Corporation strengthened interventional imaging and surgical guidance solutions for precision treatment applications.

November 2025: Expansion of ambulatory surgical centers and outpatient imaging facilities across Europe and North America increased deployment of compact and portable fluoroscopy equipment. Hospitals and specialty clinics focused on advanced image-guided interventions with improved radiation safety and patient outcomes.

October 2025: Rising advancements in flat-panel detectors, AI-powered visualization software, and dose-reduction technologies improved image clarity and reduced radiation exposure during fluoroscopy-guided procedures globally. Research institutions in the United States accelerated innovation in virtual fluoroscopy and magnetic tracking technologies for interventional guidance.

September 2025: Increasing healthcare infrastructure modernization initiatives across India, Southeast Asia, and Middle East regions accelerated installation of advanced fluoroscopy systems in tertiary hospitals and specialty diagnostic centers. Mindray Medical International and Fujifilm Holdings Corporation expanded affordable imaging solutions targeting emerging healthcare markets.

August 2025: Growing demand for mobile C-arms and point-of-care fluoroscopy systems improved adoption of flexible imaging platforms across orthopedic, pain management, and trauma applications globally. Philips Healthcare introduced advanced motorized mobile C-arm systems supporting complex interventional procedures with enhanced imaging quality.

July 2025: Rising collaborations between imaging technology providers and healthcare institutions accelerated development of AI-integrated fluoroscopy platforms and advanced workflow management systems worldwide. Siemens Healthineers received regulatory clearance for advanced radiography and fluoroscopy systems supporting integrated diagnostic imaging applications.

June 2025: Increasing focus on minimally invasive surgeries and precision-guided interventions supported strong growth in fluoroscopy equipment adoption globally. North America maintained market leadership, while Asia-Pacific emerged as the fastest growing regional market driven by expanding healthcare investments and rising chronic disease burden.

Key Players
Siemens Healthcare | GE Healthcare | Philips Healthcare | Carestream Health, Inc. | Canon Medical Systems | Hitachi Medical Systems | Shimadzu Corporation | Ziehm Imaging GmbH | Fujifilm Medical Systems | Lepu Medical Technology | Others

Key Highlights
Siemens Healthcare - Holds a 16.1% share, driven by advanced fluoroscopy imaging systems, AI-enabled diagnostic technologies, and strong hospital imaging infrastructure capabilities.

GE Healthcare - Holds a 14.0% share, supported by high-performance fluoroscopic imaging platforms, real-time interventional imaging innovation, and extensive global healthcare distribution networks.

Philips Healthcare - Holds a 12.3% share, fueled by image-guided therapy solutions, advanced minimally invasive procedure support technologies, and integrated cardiovascular imaging systems.

Carestream Health, Inc. - Holds a 9.7% share, driven by digital radiography expertise, scalable fluoroscopy workflow solutions, and expanding diagnostic imaging software capabilities.

Canon Medical Systems - Holds an 8.1% share, supported by advanced imaging visualization technologies, low-dose fluoroscopy systems, and strong radiology equipment innovation capabilities.

Hitachi Medical Systems - Holds a 6.7% share, powered by precision diagnostic imaging technologies, integrated radiology systems, and expanding healthcare imaging applications.

Shimadzu Corporation - Holds a 5.4% share, driven by advanced fluoroscopic and angiographic imaging systems, strong interventional radiology expertise, and high-resolution imaging innovation.

Ziehm Imaging GmbH - Holds a 4.6% share, supported by mobile C-arm imaging leadership, intraoperative fluoroscopy technologies, and growing adoption in orthopedic and surgical procedures.

Fujifilm Medical Systems - Holds a 3.8% share, fueled by digital imaging solutions, advanced image processing technologies, and expanding healthcare diagnostic infrastructure.

Lepu Medical Technology - Holds a 2.9% share, driven by cost-effective imaging equipment manufacturing, growing healthcare technology adoption, and expanding medical device distribution across emerging markets.

Others - Hold a combined 16.4% share, comprising regional imaging equipment manufacturers, radiology technology providers, and emerging healthcare device companies advancing fluoroscopy and real-time diagnostic imaging solutions globally.

Purchase Corporate License | Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=fluoroscopy-equipment-market?sai-v

Market Drivers

Increasing prevalence of cardiovascular diseases, orthopedic disorders, gastrointestinal conditions, and chronic pain management procedures is significantly driving demand for fluoroscopy equipment globally.

Growing adoption of minimally invasive surgical and interventional procedures is accelerating expansion of the fluoroscopy equipment market across hospitals and specialty care centers.

Rising demand for real-time imaging guidance during orthopedic surgeries, angiography, catheterization, and pain management procedures is strengthening utilization of advanced fluoroscopy systems.

Increasing number of image-guided diagnostic and therapeutic interventions is supporting continuous market growth worldwide.

Expansion of geriatric population and rising incidence of chronic diseases requiring interventional imaging procedures are contributing to higher adoption of fluoroscopy technologies.

Continuous technological advancements in flat-panel detectors, digital fluoroscopy systems, AI-assisted imaging software, and low-dose radiation technologies are improving imaging precision and patient safety.

Growing healthcare expenditure, improving diagnostic imaging infrastructure, and increasing awareness regarding minimally invasive treatment approaches are further propelling market development globally.

Industry Developments

Rapid advancement in AI-powered fluoroscopy imaging systems improving automated image enhancement, workflow optimization, and procedural accuracy.

Increasing adoption of mobile C-arm fluoroscopy systems enhancing flexibility and imaging accessibility in surgical suites and emergency care settings.

Growing investments in low-radiation fluoroscopy technologies supporting improved patient safety and regulatory compliance in diagnostic imaging procedures.

Expansion of hybrid operating rooms integrating fluoroscopy systems with advanced imaging and surgical navigation platforms improving procedural efficiency.

Rising collaborations among medical imaging companies, healthcare institutions, and surgical technology providers accelerating innovation in fluoroscopic imaging solutions.

Strategic product launches and regulatory approvals for next-generation digital fluoroscopy systems supporting global market commercialization.

Continuous innovation in cloud-based imaging platforms, real-time data integration, and AI-assisted diagnostic technologies improving operational efficiency and clinical outcomes.

Regional Insights

North America 39.6% share: "Leads the market due to advanced healthcare infrastructure, high adoption of minimally invasive procedures, strong presence of leading medical imaging companies, and increasing demand for real-time image-guided interventions."

Europe 28.2% share: "Growth supported by rising geriatric population, increasing orthopedic and cardiovascular procedures, favorable reimbursement frameworks, and growing adoption of advanced diagnostic imaging technologies."

Asia Pacific 24.9% share: "Fastest-growing region driven by improving healthcare infrastructure, rising healthcare expenditure, increasing chronic disease prevalence, and expanding investments in medical imaging technologies in countries such as China, India, Japan, and South Korea."

Latin America 4.1% share: "Emerging growth supported by improving diagnostic imaging access, increasing healthcare modernization initiatives, and rising adoption of minimally invasive treatment technologies."

Middle East & Africa 3.2% share: "Gradual growth driven by expanding healthcare infrastructure, increasing investments in advanced imaging systems, and growing awareness regarding image-guided diagnostic procedures."

Speak to our analyst and get customization in the report as per your requirements:https://www.datamintelligence.com/customize/fluoroscopy-equipment-market?sai-v

Key Segments

➥ By Product

Fluoroscopy Systems: Represents the dominant segment, driven by increasing demand for real-time diagnostic imaging, minimally invasive procedures, and advanced radiographic visualization technologies.

Fixed C-arms: Represents a significant segment, supported by widespread installation in hospitals and specialty surgical suites for high-volume interventional imaging procedures.

Mobile C-arms: Represents a rapidly growing segment, fueled by rising adoption in orthopedic, trauma, and ambulatory surgical settings due to portability and procedural flexibility.

➥ By Application

Surgical Applications: Represents the dominant segment, driven by growing volume of minimally invasive surgeries and increasing need for real-time intraoperative imaging guidance.

Neurosurgeries: Represents a significant segment, supported by rising demand for precise imaging during spinal and cranial surgical procedures.

Cardiovascular Surgeries: Represents a rapidly growing segment, fueled by increasing prevalence of cardiovascular diseases and expanding adoption of image-guided cardiac interventions.

Orthopedic & Trauma Surgeries: Represents a substantial segment, driven by increasing incidence of fractures, musculoskeletal disorders, and demand for accurate surgical navigation systems.

Gastrointestinal Surgeries: Represents a growing segment, supported by rising utilization of fluoroscopy-guided procedures in digestive tract diagnostics and interventions.

Urology & Nephrology: Represents a significant segment, fueled by increasing use of fluoroscopic imaging in kidney stone management and urinary tract procedures.

Cardiology: Represents a dominant diagnostic segment, driven by extensive utilization in angiography, catheterization, and cardiac imaging procedures.

Gastroenterology: Represents a growing segment, supported by increasing adoption in endoscopic and gastrointestinal imaging applications.

Other Diagnostic Applications: Represents an emerging segment, fueled by expanding use of fluoroscopy technologies in pain management, vascular imaging, and interventional radiology procedures.

➥ By End-User

Hospitals: Represents the dominant segment, driven by availability of advanced imaging infrastructure, high patient volumes, and increasing number of image-guided surgical procedures.

Mobile Imaging Centers: Represents a growing segment, supported by rising demand for flexible and remote diagnostic imaging services across healthcare facilities.

Diagnostic Centers: Represents a significant segment, fueled by increasing outpatient imaging procedures and growing focus on early disease diagnosis.

Others: Represents a moderate segment, driven by expanding adoption in ambulatory surgical centers, specialty clinics, and academic research institutions.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact:
Fabian
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, DataM Intelligence 4market Research LLP, Lalitha Nagar, Habsiguda, Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
UK: +44 161-870-5507
Email: fabian@datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.